BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Staging
9 results:

  • 1. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
    Arakelyan J; Zohrabyan D; Philip PA
    Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. C24-Ceramide Drives Gallbladder cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation.
    Zhang Y; Wang H; Chen T; Wang H; Liang X; Zhang Y; Duan J; Qian S; Qiao K; Zhang L; Liu Y; Wang J
    Hepatology; 2021 Feb; 73(2):692-712. PubMed ID: 32374916
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [What is new in the pathology of pancreatic neuroendocrine tumors?].
    Komminoth P; Perren A
    Pathologe; 2015 May; 36(3):220-8. PubMed ID: 25941099
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Santhanam P; Taïeb D
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PI3K-AKT-mtor-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.
    Briest F; Grabowski P
    Theranostics; 2014; 4(4):336-65. PubMed ID: 24578720
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
    Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression of PTEN and mtor in pancreatic neuroendocrine tumors.
    Han X; Ji Y; Zhao J; Xu X; Lou W
    Tumour Biol; 2013 Oct; 34(5):2871-9. PubMed ID: 23686804
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.
    Alexandraki KI; Kaltsas G
    Endocrine; 2012 Feb; 41(1):40-52. PubMed ID: 22124940
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.